Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology Practice

Pfizer

Projects that will be considered for Pfizer support will focus on increasing community healthcare professional understanding and competence in the following areas:

• Explore treatment options for patients with relapsed/refractory DLBCL, taking into consideration efficacy, safety, and patient-specific factors

• Therapy management strategies to reduce toxicity and optimize outcomes for patients with R/R DLBCL

• Mechanisms of drug-resistance/loss of response with emerging treatments

Examples of educational formats that will be considered under this RFP include but are not limited to:

• Professional medical society programs with wide reach to community oncologists caring for patients with DLBCL.

• Interactive learning, case-based learning, workshops, tumor boards

• Digital platforms (e.g., videos, podcasts, infographics, animations, social media-linked content)

• On-agenda educational sessions during local/regional live conferences

• Grand rounds – single events or series

• Online articles, newsletter articles, training courses, webinars and downloadable practice resources

Expected Approximate Monetary Range of Grant Applications:

• Individual projects requesting up to $250,000 will be considered. The estimated total available budget related to this RFP is $750,000.

• Expected typical grant range: $50,000 to $250,000. For example, smaller, local, or single healthcare institution projects should be at the lower end of this range.

• Award amounts include direct costs, institutional overhead costs (capped at 28% per Pfizer policy), and indirect costs.

Key Dates: • RFP release date: April 17, 2025

• Grant Application due date: June 12, 2025 Please note the deadline is 23:59 Eastern Standard Time (e.g., New York, GMT -5).

• Anticipated Grant Award Notification Date: July 17, 2025 • Grants will be distributed following a fully executed agreement.

• Anticipated Approximate Project Start and End Dates: August 2025 to February 2027 (18 months preferred length; projects may be shorter or longer than 18 months)

Specialties

Oncology

Eligibility Requirements

• Applicant organizations to this RFP must be based in the United States.

• The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; hospitals and healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

• Only organizations are eligible to receive grants, not individuals or physician-owned medical practices or individual-physician-owned organizations.

• If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.

• For projects offering continuing education credit in the United States, the requesting organization must be accredited.

Sponsor Details

Sponsor Institute/Organizations: Pfizer

Sponsor Type: Corporate/Non-Profit

Address: 66 Hudson Boulevard East New York, NY 10001-2192 USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity